← SEVENTY3®

Seventy3 OS — Terms of Service

Seventy3 Group Ltd Effective date: 13 July 2026 · Last updated: 13 July 2026 · Version 1.0

These Terms of Service govern access to and use of the Seventy3 OS platform. They form a binding agreement between Seventy3 Group Ltd and the customer (a healthcare clinic) named on the order form or sign-up. Please read them carefully.

1. The parties

These Terms are a binding contract between:

(1) Seventy3 Group Ltd, a company incorporated in England and Wales with company number 16392260 and registered office at Suite 21, Call House, Enfield Street, Leeds, England, LS7 1RF ("Seventy3", "we", "us", "our"); and (2) the customer identified on the order form or sign-up flow that incorporates these Terms ("you", "your", "the Clinic").

Seventy3 supplies a software-as-a-service platform called "Seventy3 OS" (the "Platform"). These Terms govern your access to and use of the Platform.

2. Definitions

  • "Agreement" means these Terms together with the Order Form, the Privacy Policy, the Data Processing Agreement, and the Acceptable Use Policy.
  • "Clinic Data" means all data, content, and information uploaded, submitted, or generated through the Platform by you or your authorised users, including patient records, clinical notes, and contact details.
  • "Authorised Users" means individuals authorised by you to access the Platform on your behalf (e.g., therapists, receptionists, and clinic administrators).
  • "Patients" means the individual end-clients of the Clinic whose personal data is processed through the Platform.
  • "Order Form" means the online sign-up flow, written quote, or other document that records your subscription to the Platform.
  • "Subscription Fees" means the fees set out in the Order Form, payable monthly.
  • "Subscription Term" means the rolling monthly period during which you have access to the Platform.
  • "UK GDPR" means the UK General Data Protection Regulation as defined in the Data Protection Act 2018.

3. The Platform

3.1 What Seventy3 OS does. The Platform provides clinic operating system functionality for therapy and performance clinics, including (without limitation):

  • Lead capture, automated booking, and appointment management.
  • AI-assisted receptionist functions handling inbound calls and SMS communications.
  • Email and SMS automation for appointment reminders, reactivation, and patient communications.
  • A unified clinic dashboard, including calendar synchronisation and Stripe-based payment processing.
  • AI-assisted clinical documentation, including transcription and SOAP-format note generation.
  • Exercise plan creation, delivery, and tracking.
  • Membership and retention management.

3.2 Beta and pre-release features. Seventy3 may make features available on a beta, pilot, or evaluation basis. Such features are provided "as-is" and may be withdrawn, modified, or changed at any time without notice.

3.3 AI-assisted clinical features — important limitations. The Platform's AI-assisted clinical features (including treatment sequencing suggestions, exercise recommendations, and any clinical prompts) are decision-support tools only, not medical devices, and do not provide medical advice, diagnosis, or treatment. All clinical decisions remain the sole responsibility of the registered healthcare professional using the Platform. The Clinic and the responsible clinician must review, validate, and confirm any AI-generated content before it is acted upon, communicated to a Patient, or included in a clinical record. Seventy3 is not a healthcare provider and does not practise medicine, physiotherapy, osteopathy, sports therapy, or any other regulated clinical discipline.

3.3.1 Nature of the AI outputs. The Platform does not diagnose, does not recommend that any specific treatment be administered to any specific Patient, and does not produce any output that is applied to a Patient automatically or without human intervention. Every AI-generated output is presented as a draft that requires the independent review, clinical judgement, and express confirmation of a registered clinician before it is used, communicated, or recorded. The Platform performs no function on an individual Patient's data for the purpose of that individual's diagnosis, prevention, monitoring, prediction, prognosis, or treatment, and is not intended by Seventy3 to be relied upon for any such purpose.

3.3.2 Regulatory responsibility of the Clinic. The Clinic is responsible for determining whether its own configuration or use of the Platform's outputs constitutes a regulated activity (including any activity regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) or any successor body) and for obtaining and maintaining any registration, approval, or clinical governance measure that such use requires. The Clinic must not configure or use the Platform in a manner that would cause it to function as a medical device, and any such configuration or use is at the Clinic's sole risk and responsibility.

3.3.3 No reliance without confirmation. The Clinic acknowledges and agrees that reliance on any AI-generated output without the review and confirmation required by clause 3.3 is a breach of these Terms and is at the Clinic's sole risk. Liability arising from such reliance is allocated to the Clinic under clause 13.2(iv).

4. Account, access, and authorised users

4.1 Account creation. To use the Platform you must create an account, providing accurate and complete information. You must keep your account information up to date.

4.2 Authorised Users. You may permit Authorised Users to access the Platform on your behalf. You are responsible for the acts and omissions of all Authorised Users as if they were your own.

4.3 Account security. You must keep account credentials confidential, use multi-factor authentication where offered, and notify Seventy3 promptly of any suspected unauthorised access.

4.4 Eligibility. The Platform is offered to UK-based businesses operating regulated or recognised therapy and performance clinic services. By accepting these Terms you confirm that the Authorised Users include at least one appropriately qualified clinician (e.g., HCPC-registered physiotherapist, GOsC-registered osteopath, or equivalent) where the Platform is used in connection with clinical services.

5. Subscription, fees, and payment

5.1 Subscription. The Platform is supplied on a rolling monthly basis. Your Subscription Term begins on the date of first access and continues month-to-month until terminated in accordance with these Terms.

5.2 Subscription Fees. Subscription Fees are as set out on the Order Form. Standard pricing at the date of these Terms is:

  • Founding Member: £125 setup fee + £125 per month, with the lifetime price lock described in clause 5.4 (limited to the first 30 customers).
  • Public pricing: £175 setup fee + £175 per month.

All fees are exclusive of VAT, which will be added at the prevailing rate where applicable.

5.3 Setup fee. The setup fee is payable on sign-up and is non-refundable once onboarding has commenced.

5.4 Founding Member lifetime price lock. If you sign up under the Founding Member tier, Seventy3 commits to honour the locked monthly Subscription Fee specified on your Order Form for as long as your subscription remains continuously active, subject to all of the following:

  • Continuous subscription. The price lock applies only while your subscription is continuously active. If you cancel, terminate, or have your subscription terminated for any reason (including for non-payment under clause 5.6), the price lock is permanently lost. If you re-subscribe at a later date, you will do so at then-current public pricing.
  • Scope of the lock. The price lock applies to the service tier to which you are subscribed at the time the lock is granted, including all incremental improvements and enhancements made to that tier from time to time. The price lock does not extend to genuinely new product modules or service tiers introduced after your subscription begins (for example, a new add-on module or a separately-priced tier). Such new offerings will be made available to Founding Members at a meaningful discount to then-current public pricing for that new offering, the precise level of which will be communicated at the time the new offering is launched.
  • Payment failure. If a Subscription Fee payment fails and remains unpaid for more than 14 days after written notice, your subscription will be deemed cancelled for the purposes of this clause and the Founding Member price lock will be permanently lost.
  • No transfer. The Founding Member price lock is personal to the Clinic and is not transferable to any successor, assignee, or affiliate, save with Seventy3's prior written consent.
  • Cost pass-through. The price lock applies to the Subscription Fee only. It does not fetter Seventy3's right to pass through, at cost and without mark-up, any new or increased third-party fee, tax, duty, levy, or regulatory charge that Seventy3 becomes obliged to pay in connection with providing the Platform to the Clinic (for example, a material increase in telephony, SMS, or AI-model costs charged by a sub-processor). Seventy3 will give at least 30 days' written notice of any such pass-through, together with reasonable evidence of the underlying cost change.
  • Not a commitment to perpetual provision. The price lock fixes price; it does not oblige Seventy3 to provide the Platform, the relevant tier, or any particular feature indefinitely. Seventy3's rights to modify or discontinue features (clause 3), and to terminate for convenience on 60 days' notice with a refund of prepaid fees (clause 6.3), take precedence over and are not limited by this clause 5.4. The price lock confers no right to continued provision beyond a valid termination under clause 6.3.

5.5 Payment terms. Subscription Fees are charged monthly in advance via Stripe. By providing payment details you authorise Seventy3 to charge the relevant amounts on each renewal date.

5.6 Late payment and suspension. If a Subscription Fee remains unpaid more than 7 days after the due date, Seventy3 may suspend your access to the Platform until payment is received. After 30 days of non-payment, Seventy3 may terminate the Agreement under clause 12. Seventy3 may also charge interest on overdue amounts at 4% above the Bank of England base rate, compounded monthly.

5.7 Price changes. Seventy3 may revise public pricing on 30 days' written notice. For Founding Members the price lock in clause 5.4 takes precedence. For all other customers, continued use of the Platform after a price change takes effect constitutes acceptance of the new pricing.

5.8 No refunds. Subscription Fees are non-refundable. Cancellation does not entitle you to a refund of fees paid for any partial month or for the setup fee. Statutory consumer rights do not apply because the Platform is supplied to businesses, not consumers.

6. Cancellation and termination

6.1 Cancellation by you. You may cancel your subscription at any time via the Platform settings or by written notice to Seventy3. Cancellation is effective immediately, but you will retain access to the Platform until the end of the then-current paid billing month. No refund is given for the unused portion of the month.

6.2 Termination by Seventy3 for cause. Seventy3 may suspend or terminate your access immediately, without refund, if:

  • you materially breach these Terms (including the Acceptable Use Policy) and the breach is not remediable, or is not remedied within 14 days of written notice;
  • you fail to pay Subscription Fees under clause 5.6;
  • you become insolvent or enter administration, liquidation, or any analogous process;
  • Seventy3 reasonably believes that continued provision of the Platform to you would expose Seventy3 to material legal, regulatory, or reputational risk.

6.3 Termination for convenience by Seventy3. Seventy3 may terminate the Agreement on 60 days' written notice for any reason. In such case, Seventy3 will refund any prepaid fees covering periods after the effective termination date.

6.4 Effect of termination. On termination:

  • All licences granted to you cease immediately.
  • You must cease accessing or using the Platform and the Marks.
  • Sections that by their nature should survive (including IP, liability, indemnity, governing law, confidentiality, and dispute resolution) survive.
  • Clinic Data export and deletion are governed by clause 7.

7. Data export and deletion on termination

7.1 Export window. For a period of 60 days following termination or expiry of the Agreement (the "Export Period"), you may export your Clinic Data via the Platform's standard export functions, in commonly-used machine-readable formats (CSV and JSON where applicable).

7.2 Deletion. Following the Export Period, Seventy3 will delete all Clinic Data from production systems within 30 days. Clinic Data will be expunged from routine backups within the standard backup rotation cycle of 90 days.

7.3 Retained data. Seventy3 may retain (i) account, billing, and accounting records for 6 years to comply with HMRC and Limitation Act 1980 requirements, and (ii) aggregated and anonymised usage data (containing no personal data) indefinitely for product analytics and improvement.

7.4 Patient records. You acknowledge that, as the data controller, you are responsible for ensuring that Patient clinical records are retained for the periods required by your professional regulator (e.g., HCPC, GOsC, GMC) and applicable law. The retention and deletion practices in clauses 7.1 to 7.3 relate to Seventy3's obligations as data processor and do not constitute professional record-keeping advice. If you require longer retention than the Export Period, you must export and store the relevant records yourself before the Export Period ends.

8. Acceptable use

Your use of the Platform is subject to the Acceptable Use Policy, which forms part of the Agreement. Material breach of the Acceptable Use Policy is a material breach of these Terms.

9. Data protection

9.1 Roles. In respect of Patient data, you are the data controller and Seventy3 is the data processor under UK GDPR. The terms of processing are set out in the Data Processing Agreement, which forms part of the Agreement. In respect of Authorised User account data and billing data, Seventy3 is the data controller. The Privacy Policy describes how Seventy3 processes that data.

9.2 Customer obligations. You warrant that:

  • you have all necessary lawful bases under UK GDPR Articles 6 and 9 to process Patient data and to instruct Seventy3 to process such data on your behalf;
  • you provide all required privacy notices to Patients, including disclosure that Seventy3 (and its sub-processors) processes their data;
  • you respond to data subject requests, complaints, and regulator enquiries in your capacity as controller, with assistance from Seventy3 as set out in the DPA.

10. Intellectual property

10.1 Seventy3's rights. Seventy3 (and its licensors) own all right, title, and interest in and to the Platform, the Marks, all underlying technology, models, algorithms, and improvements thereto. No rights are granted except as expressly set out in these Terms.

10.2 Limited licence to use. Subject to your compliance with these Terms, Seventy3 grants you a limited, non-exclusive, non-transferable, revocable licence during the Subscription Term to access and use the Platform for your internal business purposes.

10.3 Restrictions. You must not (and must not permit any third party to):

  • reverse engineer, decompile, or attempt to derive the source code, models, or algorithms underlying the Platform;
  • copy, modify, or create derivative works of the Platform;
  • rent, lease, sell, sublicense, or transfer access to the Platform;
  • use the Platform to build or train any competing product or service;
  • use the Platform in violation of these Terms or applicable law.

10.4 Clinic Data. As between the parties, Clinic Data is and remains your property. You grant Seventy3 a worldwide, royalty-free licence to use Clinic Data solely to (i) provide the Platform to you, (ii) prevent or address service or technical problems, and (iii) comply with applicable law. Seventy3 will not use Clinic Data to train its own models or those of any third party.

10.5 Feedback. If you provide Seventy3 with suggestions, ideas, or feedback ("Feedback"), you grant Seventy3 a perpetual, irrevocable, royalty-free licence to use the Feedback in connection with the Platform.

10.6 Marketing. With your prior written consent (which may be given by email), Seventy3 may identify you as a Seventy3 OS customer in marketing materials and use your name and logo for that purpose. You may revoke this consent on 30 days' written notice.

11. Service levels and availability

11.1 Reasonable efforts. Seventy3 will use commercially reasonable efforts to make the Platform available 24/7, subject to scheduled maintenance and circumstances beyond its reasonable control.

11.2 No guaranteed uptime. Seventy3 does not warrant or guarantee any specific uptime percentage, and no service credits are payable for downtime. Customers requiring contractual uptime guarantees should contact Seventy3 to discuss enterprise terms.

11.3 Maintenance. Seventy3 will give reasonable advance notice of planned maintenance where possible and will use reasonable efforts to schedule maintenance outside peak clinic hours.

12. Warranties and disclaimers

12.1 Mutual warranties. Each party warrants that it has the legal capacity and authority to enter into the Agreement.

12.2 Seventy3's limited warranty. Seventy3 warrants that it will provide the Platform with reasonable skill and care.

12.3 Disclaimer. Except as expressly set out in the Agreement, the Platform is provided "as is" and "as available". To the maximum extent permitted by law, Seventy3 disclaims all other warranties, conditions, and representations, whether express or implied, statutory or otherwise, including any warranty of merchantability, fitness for a particular purpose, non-infringement, or that the Platform will be uninterrupted, error-free, or secure.

13. Indemnities

13.1 Seventy3's IP indemnity. Seventy3 will defend you against any third-party claim that the Platform, used in accordance with the Agreement, infringes that third party's UK intellectual property rights, and will pay damages finally awarded against you in such claim or any settlement agreed by Seventy3, provided that you (i) notify Seventy3 promptly of the claim, (ii) give Seventy3 sole control of the defence and settlement, and (iii) provide reasonable cooperation. This indemnity does not apply to claims arising from (a) Clinic Data, (b) your use of the Platform in breach of the Agreement, or (c) modifications or combinations of the Platform not made by Seventy3. Seventy3's total aggregate liability under this clause 13.1 is subject to the Liability Cap in clause 14.3. If Seventy3 reasonably believes the Platform infringes, Seventy3 may at its option and expense (x) procure the right for you to continue using the Platform, (y) modify or replace the Platform so it is non-infringing, or (z) terminate the Agreement and refund any prepaid fees covering the period after termination; this is your sole and exclusive remedy for any infringement claim.

13.2 Customer indemnity. You will indemnify and keep indemnified Seventy3 (and its officers, employees, and sub-processors) against all losses, damages, costs, and expenses (including reasonable legal fees) arising from any claim, demand, or proceeding relating to (i) Clinic Data, (ii) your or your Authorised Users' breach of the Agreement, (iii) your processing of Patient data in breach of UK GDPR or other applicable law, or (iv) any clinical decision or act or omission by you or any Authorised User, including any reliance on AI-assisted suggestions provided by the Platform contrary to clause 3.3. For the avoidance of doubt, and as contemplated by clause 14.1(d), your liability under this clause 13.2 is not subject to the Liability Cap or to the exclusions in clause 14.2, save that you will not be liable under this clause to the extent a loss is finally judicially determined to have been caused by Seventy3's own breach of the Agreement, negligence, or wilful misconduct.

14. Limitation of liability

14.1 Liabilities not limited. Nothing in the Agreement excludes or limits liability for: (a) death or personal injury caused by negligence; (b) fraud or fraudulent misrepresentation; (c) any liability that cannot be excluded or limited under English law; or (d) your indemnification obligations under clause 13.2. For the avoidance of doubt, Seventy3's indemnity under clause 13.1 is subject to the Liability Cap as stated in that clause.

14.2 No liability for indirect loss. Subject to clause 14.1, neither party will be liable to the other for any indirect, special, consequential, or punitive losses, or for loss of profits, loss of revenue, loss of business, loss of goodwill, loss of opportunity, or loss of anticipated savings, in each case whether arising in contract, tort (including negligence), breach of statutory duty, or otherwise.

14.3 Cap on direct liability. Subject to clause 14.1, each party's total aggregate liability under or in connection with the Agreement, whether arising in contract, tort, or otherwise, will not exceed the greater of (a) the total Subscription Fees paid or payable by you to Seventy3 in the 12 months immediately preceding the event giving rise to the claim, and (b) £10,000 (the "Liability Cap"). The parties acknowledge that this Liability Cap has been set with reference to the Subscription Fees, the allocation of risk in this Agreement (including the indemnities in clause 13), and the availability of insurance, and each party confirms that it considers the Liability Cap to be reasonable.

14.4 Data protection liability. Subject to clause 14.1, Seventy3's total aggregate liability for any breach of its obligations under UK GDPR or the Data Processing Agreement is capped at twice (2x) the Liability Cap.

15. Confidentiality

15.1 Definition. "Confidential Information" means any non-public information disclosed by one party (the "Discloser") to the other (the "Recipient") that is marked or identified as confidential or that, given its nature and the circumstances of disclosure, ought reasonably to be treated as confidential. Confidential Information includes the terms of the Agreement and any pricing.

15.2 Obligations. The Recipient will:

  • hold the Discloser's Confidential Information in strict confidence;
  • use it only as necessary to perform the Agreement;
  • disclose it only to those of its personnel who need to know and who are bound by confidentiality obligations no less protective than those in this clause.

15.3 Exceptions. Clause 15.2 does not apply to information that (a) is or becomes publicly available without breach, (b) was already known to the Recipient without restriction, (c) is independently developed by the Recipient, (d) is rightfully received from a third party without restriction, or (e) is required to be disclosed by law or regulator (with prompt notice to the Discloser where lawful).

16. Force majeure

Neither party will be liable for failure or delay in performing its obligations (other than payment) to the extent caused by circumstances beyond its reasonable control, including acts of God, war, terrorism, pandemic, governmental action, internet or telecommunications failure, or third-party service outages. The affected party will use reasonable efforts to resume performance as soon as practicable.

17. Changes to these Terms

Seventy3 may amend these Terms from time to time. For material changes, Seventy3 will give at least 30 days' written notice (which may be by email or in-Platform notice). If you do not accept the changes, your sole remedy is to cancel under clause 6.1 before they take effect. Continued use of the Platform after the effective date of changes constitutes acceptance.

18. General

18.1 Notices. Notices to Seventy3 must be sent to legal@seventy3.co or to the registered office. Notices to you may be sent to the email address on your account or via in-Platform notification.

18.2 Assignment. You may not assign or transfer the Agreement without Seventy3's prior written consent. Seventy3 may assign the Agreement, in whole or in part, to an affiliate or in connection with a merger, acquisition, or sale of assets.

18.3 Subcontracting. Seventy3 may subcontract any of its obligations but remains responsible for the performance of its subcontractors as if it had performed the relevant obligations itself.

18.4 No partnership or agency. Nothing in the Agreement creates a partnership, joint venture, agency, or employment relationship between the parties.

18.5 Third party rights. A person who is not a party to the Agreement has no rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.

18.6 Entire agreement. The Agreement constitutes the entire agreement between the parties relating to its subject matter and supersedes all prior negotiations and understandings.

18.7 Severability. If any provision of the Agreement is held to be invalid or unenforceable, that provision will be modified or severed to the minimum extent necessary, and the remaining provisions will continue in full force.

18.8 Waiver. No failure or delay by a party to exercise any right under the Agreement constitutes a waiver of that right.

19. Governing law and jurisdiction

The Agreement is governed by the laws of England and Wales. The parties submit to the exclusive jurisdiction of the courts of England and Wales for the resolution of any dispute arising out of or in connection with the Agreement.

20. Acceptance

By signing up for or accessing the Platform, you confirm that you have read, understood, and agree to be bound by these Terms, the Privacy Policy, the Data Processing Agreement, and the Acceptable Use Policy.